Angela Thedinga
Director/Board Member at NKARTA, INC.
Net worth: - $ as of 2024-05-30
Angela Thedinga active positions
| Companies | Position | Start | End |
|---|---|---|---|
| NKARTA, INC. | Director/Board Member | 2022-03-27 | - |
| Independent Dir/Board Member | 2022-03-27 | - |
Career history of Angela Thedinga
Former positions of Angela Thedinga
| Companies | Position | Start | End |
|---|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Chief Tech/Sci/R&D Officer | 2020-02-24 | 2021-09-30 |
| Corporate Officer/Principal | 2019-07-31 | 2020-02-24 | |
| AVEXIS INC | Human Resources Officer | 2018-06-30 | 2019-05-31 |
Training of Angela Thedinga
| Massachusetts Institute of Technology | Graduate Degree |
| MIT Sloan School of Management | Masters Business Admin |
| The University of North Carolina at Chapel Hill | Graduate Degree |
| University of Wisconsin | Undergraduate Degree |
Statistics
International
| United States | 8 |
Operational
| Graduate Degree | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 4 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| NKARTA, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
- Stock Market
- Insiders
- Angela Thedinga
- Experience
